Resistance to chemotherapy is a major problem for those suffering from ovarian cancer — a problem that prevents a cure from a disease dubbed the ‘silent killer.’ Now researchers are giving patients new hope with recent findings that help pinpoint the mechanisms causing chemoresistance.